The Cooper Companies, Inc.

NasdaqGS:COO

Sector

🏥 Health Care

Industries

🕶 Eyewear

🩺 Medical Instruments

💻 Telehealth

Location

United States

Market Cap

USD 13.86 B

Share Price

USD 69.47

Avg Daily Volume

2,397,385

Change (1 day)

-0.49%

Change (1 year)

-24.27%

Change (YTD)

-24.43%

The Cooper Companies, Inc. Common Stock Issued for the Trailing 12 Months (TTM) ending April 30, 2025: USD 6.40 M

The Cooper Companies, Inc. Common Stock Issued is USD 6.40 M for the Trailing 12 Months (TTM) ending April 30, 2025, a -72.17% change year over year. Common stock issued is cash received from issuing new shares of the company’s common stock.

The Cooper Companies, Inc. Common Stock Issued for the Trailing 12 Months (TTM) ending April 30, 2024 was USD 23.00 M, a 40.24% change year over year.
The Cooper Companies, Inc. Common Stock Issued for the Trailing 12 Months (TTM) ending April 30, 2023 was USD 16.40 M, a -35.94% change year over year.
The Cooper Companies, Inc. Common Stock Issued for the Trailing 12 Months (TTM) ending April 30, 2022 was USD 25.60 M, a 1,869.23% change year over year.
The Cooper Companies, Inc. Common Stock Issued for the Trailing 12 Months (TTM) ending April 30, 2021 was USD 1.30 M.

Quarterly
Annual
TTM

From:

To:

Zoom:

Key data

Date	Common Stock Issued	Common Stock Repurchased	Free Cash Flow	Operating Cash Flow

NasdaqGS: COO

The Cooper Companies, Inc.

CEO	Mr. Albert G. White III
IPO Date	Jan. 21, 1983
Location	United States
Headquarters	6101 Bollinger Canyon Road
Employees	16,000
Sector	🏥 Health Care
Industries Eyewear 🩺 Medical Instruments 💻 Telehealth

Description

The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, myopia, ocular dryness and eye fatigues in the Americas, Europe, Middle East, Africa, and Asia Pacific. The CooperSurgical segment focuses on family and women's health care, which provides medical devices, fertility, genomics, diagnostics, and contraception to health care professionals and patients worldwide. It offers surgical and office products, including PARAGARD, uterine manipulators, retractors, closure products, point of care products, LEEP products, endosee, and illuminate and fetal pillows; fertility products and services, such as fertility consumables and equipment, and embryo options and preimplantation genetic testing. The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.